Abstract
Thirty-two pregnant hypertensive patients were treated with oxprenolol administered in combination with dihydralazine as Trasipressol tablets. Before delivery, oxprenolol was demonstrable in the maternal plasma and the amniotic fluid. The free fraction of oxprenolol in the maternal serum (15% +/- 7.8; mean +/- s.d.; n = 25) was similar to that in normal serum. At the end of delivery, oxprenolol was found in both the maternal and umbilical plasma in most cases. Measurable, but low oxprenolol concentrations were present in the newborn plasma. After delivery, oxprenolol was demonstrable in the maternal plasma and breast milk. An infant weighing 3 kg and consuming 500 ml of breast milk per day would receive a maximum dose 60 times less than the normal daily dose for a hypertensive adult (4 mg/kg).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Belpaire F. M., Bogaert M. G., Rosseneu M. Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum. Eur J Clin Pharmacol. 1982;22(3):253–256. doi: 10.1007/BF00545224. [DOI] [PubMed] [Google Scholar]
- Boutroy M. J., Vert P., Bianchetti G., Dubrucq C., Morselli P. L. Infants born to hypertensive mothers treated by acebutolol. Pharmacological studies in the perinatal period. Dev Pharmacol Ther. 1982;4 (Suppl):109–115. doi: 10.1159/000457365. [DOI] [PubMed] [Google Scholar]
- Liedholm H., Melander A., Bitzén P. O., Helm G., Lönnerholm G., Mattiasson I., Nilsson B., Wåhlin-Boll E. Accumulation of atenolol and metoprolol in human breast milk. Eur J Clin Pharmacol. 1981;20(3):229–231. doi: 10.1007/BF00544603. [DOI] [PubMed] [Google Scholar]
- Lundborg P., Agren G., Ervik M., Lindeberg S., Sandstrom B. Disposition of metoprolol in the newborn. Br J Clin Pharmacol. 1981 Oct;12(4):598–600. doi: 10.1111/j.1365-2125.1981.tb01276.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mason W. D., Winer N. Pharmacokinetics of oxprenolol in normal subjects. Clin Pharmacol Ther. 1976 Oct;20(4):401–412. doi: 10.1002/cpt1976204401. [DOI] [PubMed] [Google Scholar]
- O'Hare M. F., Murnaghan G. A., Russell C. J., Leahey W. J., Varma M. P., McDevitt D. G. Sotalol as a hypotensive agent in pregnancy. Br J Obstet Gynaecol. 1980 Sep;87(9):814–820. doi: 10.1111/j.1471-0528.1980.tb04618.x. [DOI] [PubMed] [Google Scholar]
- Riley A. J. Clinical pharmacology of labetalol in pregnancy. J Cardiovasc Pharmacol. 1981;3 (Suppl 1):S53–S59. doi: 10.1097/00005344-198100031-00006. [DOI] [PubMed] [Google Scholar]
- Sandström B., Regårdh C. G. Metoprolol excretion into breast milk. Br J Clin Pharmacol. 1980 May;9(5):518–519. doi: 10.1111/j.1365-2125.1980.tb05850.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sioufi A., Colussi D., Mangoni P. Gas chromatographic determination of oxprenolol in human plasma. J Chromatogr. 1983 Nov 11;278(1):185–188. doi: 10.1016/s0378-4347(00)84772-6. [DOI] [PubMed] [Google Scholar]